Chinese Proverbs
|
5
|
Resverlogix Corp.
|
Jan 31, 2016 02:23AM
|
Re: Zenith Updates
|
5
|
Zenith Epigenetics
|
Jan 30, 2016 01:05PM
|
RVX/Zenith accounting for Royalty Preferred Shares Dividends
|
3
|
Zenith Epigenetics
|
Jan 30, 2016 12:43PM
|
RVX/Zenith accounting for Royalty Preferred Shares Dividends
|
8
|
Resverlogix Corp.
|
Jan 30, 2016 11:55AM
|
Re: RVX/Zenith Financial Statement Disparity - Royalty Preferred Shares
|
2
|
Resverlogix Corp.
|
Jan 26, 2016 11:07AM
|
Re: RVX/Zenith Financial Statement Disparity - Royalty Preferred Shares
|
1
|
Resverlogix Corp.
|
Jan 24, 2016 01:37PM
|
Re: RVX/Zenith Financial Statement Disparity - Royalty Preferred Shares
|
1
|
Resverlogix Corp.
|
Jan 23, 2016 09:20AM
|
Re: RVX/Zenith Financial Statement Disparity - Royalty Preferred Shares
|
3
|
Resverlogix Corp.
|
Jan 22, 2016 06:31PM
|
RVX/Zenith Financial Statement Disparity - Royalty Preferred Shares
|
4
|
Resverlogix Corp.
|
Jan 22, 2016 05:19PM
|
RVX/Zenith Financial Statement Disparity - Royalty Preferred Shares
|
3
|
Zenith Epigenetics
|
Jan 22, 2016 05:17PM
|
Re: RVX LIFESCIENCES ART
|
3
|
Resverlogix Corp.
|
Jan 20, 2016 08:40PM
|
Re: Zacks new analyst research update price increase and buy rating
|
6
|
Resverlogix Corp.
|
Jan 19, 2016 09:11PM
|
Re: Zacks new analyst research update price increase and buy rating
|
4
|
Resverlogix Corp.
|
Jan 19, 2016 01:04PM
|
Re: Epigenetics market to reach $16.3 Billion in 6 years (article)
|
4
|
Resverlogix Corp.
|
Jan 18, 2016 06:12PM
|
Re: Epigenetics market to reach $16.3 Billion in 6 years (article)
|
3
|
Resverlogix Corp.
|
Jan 17, 2016 08:23PM
|
A Critical Mass
|
10
|
Resverlogix Corp.
|
Jan 09, 2016 09:09PM
|
Re: AGM - Jan 7, 2016 - Details
|
4
|
Zenith Epigenetics
|
Jan 08, 2016 02:02PM
|
Re: AGM - Jan 7, 2016 - Details
|
2
|
Zenith Epigenetics
|
Jan 08, 2016 12:52PM
|
Re: Rough waters on the investment ocean.....
|
5
|
Resverlogix Corp.
|
Jan 08, 2016 10:36AM
|
Re: AGM - High Level Summary
|
2
|
Zenith Epigenetics
|
Jan 07, 2016 07:35PM
|